American College of Clinical Pharmacy
      Search      Cart
         

Hematology/Oncology PRN Focus Session -- Chemotherapy and Immunotherapy-Induced Endocrinopathies

Saturday, October 07, 2017 from 1:45 PM to 3:15 PM MST at Phoenix Convention Center North Building Street Level: North Ballroom 120D

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-134-L01-P
Activity Type: A Knowledge-Based Activity


Speakers
  • Marco  Martino, Pharm.D., MBA, BCPS, BCOPModerator: Marco Martino, Pharm.D., MBA, BCPS, BCOP
    Operations Team Lead (Hematology/Oncology), Northwestern Medicine, Chicago, Illinois
      View Biography

Chemotherapy-Induced Endocrinopathies
1:45 PM

Speakers
  • LeAnn B. Norris, Pharm.D., FCCP, BCPS, BCOPSpeaker: LeAnn B. Norris, Pharm.D., FCCP, BCPS, BCOP
    Clinical Associate Professor, Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina
      View Biography


Learning Objectives
1. List the chemotherapeutic agents that can cause endocrine toxicities.
2. Describe the subjective and objective presentation of chemotherapy-induced endocrine toxicities.
3. Discuss the appropriate treatment of chemotherapy-induced endocrine toxicities.
Immunotherapy-Induced Endocrinopathies
2:30 PM to 3:15 PM

Speakers
  • Patrick J. Medina, Pharm.D., BCOPSpeaker: Patrick J. Medina, Pharm.D., BCOP
    Associate Professor, University of Oklahoma, College of Pharmacy, Oklahoma City, Oklahoma


Learning Objectives
1. Identify and describe immunotherapy agents utilized for the treatment of cancer.
2. Identify toxicities and side effects of immunotherapy agents utilized for the treatment of cancer.
3. Explain how to manage side effects of these immunotherapy agents utilized for the treatment of cancer.